Skip Navigation

ALS News

field with sun shining

Breaking Research

May 11
2017
Breaking Research
The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease
Rea entire press release on www.fda.gov
Nov 5
2015
ALS Headlines, Breaking Research, Donor Stories, Ice Bucket Challenge, Packard Center News
Molecular differences between C9orf72 mutation-associated and sporadic ALS